Back to search

Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors

Data up to Jan 2025

Published2003
Citations97
References26

Total Citations Per Year

Abstract

References (26)

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

1996 • 6,878 citations

Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

2002 • 2,711 citations

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

2000 • 2,700 citations

Clinical translation of angiogenesis inhibitors

2002 • 1,518 citations

Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes

1985 • 1,292 citations

THE EPHRINS AND EPH RECEPTORS IN NEURAL DEVELOPMENT

1998 • 1,082 citations

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185

1986 • 1,020 citations

Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice

1999 • 990 citations

The binding site for C1q on IgG

1988 • 556 citations

Regulated Cleavage of a Contact-Mediated Axon Repellent

2000 • 522 citations

Eph receptors and ephrins: effectors of morphogenesis

1999 • 445 citations

A model of angiogenesis in the mouse cornea.

1996 • 411 citations

The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

2000 • 379 citations

Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis

1995 • 368 citations

The ephrins and Eph receptors in angiogenesis

2002 • 336 citations

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo

2002 • 317 citations

Eph receptors and ephrin ligands: embryogenesis to tumorigenesis

2000 • 297 citations

Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.

1999 • 292 citations

Localization of the binding site for the human high-affinity Fc receptor on IgG

1988 • 287 citations

Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.

2001 • 259 citations

Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models

1996 • 246 citations

Angiogenesis modulation in cancer research: novel clinical approaches

2002 • 181 citations

Ephrins and their receptors: a repulsive topic?

1997 • 154 citations

Vascular patterning by Eph receptor tyrosine kinases and ephrins

2002 • 111 citations

Characterization of B61, the Ligand for the Eck Receptor Protein-Tyrosine Kinase

1995 • 65 citations

Molecular definition of interaction sites on human IgG for Fc receptors (huFcγR)

1990 • 61 citations

Cited By (0)

Loading...
Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors (2003) – Neoplasia | Metascience Observatory Explorer